Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology

European Journal of Heart Failure - Tập 20 Số 1 - Trang 3-15 - 2018
Ugo Corrà1, Piergiuseppe Agostoni2,3, Stefan D. Anker4, Andrew J.S. Coats5, María G. Crespo‐Leiro6, Rudolf A. de Boer7, Veli‐Pekka Harjola8, Loreena Hill9, Mitja Lainščak10,11, Lars H. Lund12,13, Marco Metra14, Piotr Ponikowski15, Jillian Riley16, Petar Seferović17, Massimo Piepoli18
1Cardiology Division, Istituti Clinici Scientifici Maugeri, Centro Medico di Riabilitazione di Veruno, Veruno, Novara, Italy
2Cardiology Center of Monzino, IRCCS, Milan, Italy
3Cardiology Center of Monzino, IRCCS, Milan, Italy; and Cardiovascular Section, Department of Clinical Sciences and Community Health University of Milan Milan Italy
4Division of Cardiology and Metabolism ‐ Heart Failure, Cachexia & Sarcopenia, Department of Cardiology (CVK) and Berlin‐Brandenburg Center for Regenerative Therapies (BCRT), at Charité University Medicine, Berlin; Department of Cardiology and Pneumology University Medicine Göttingen (UMG), Göttingen, Germany; German Center for Cardiovascular Research (DZHK) Berlin Germany
5University of Warwick, Coventry, UK
6Heart Failure and Heart Transplant Unit Complejo Hospitalario Universitario A Coruña (CHUAC), CIBERCV La Coruña Spain
7University Medical Center Groningen, Groningen, The Netherlands
8Emergency Medicine, University of Helsinki, Department of Emergency Medicine and Services Helsinki University Hospital Helsinki Finland
9School of Nursing and Midwifery, Queen's University Belfast, UK
10Faculty of Medicine University of Ljubljana; and Center for Heart Failure, General Hospital Murska Sobota Slovenia
11Faculty of Medicine, University of Ljubljana
12Department of Medicine, Karolinska Institutet
13Department of Medicine, Karolinska Institutet, and Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden
14University of Brescia, Italy
15Wroclaw Medical University, Wroclaw, Poland
16National Heart and Lung Institute, Imperial College, London, UK
17Internal Medicine, University of Belgrade School of Medicine, Belgrade, Serbia
18Heart Failure Unit, Cardiac Department, Guglielmo da Saliceto Hospital, Piacenza, Italy

Tóm tắt

Traditionally, the main indication for cardiopulmonary exercise testing (CPET) in heart failure (HF) was for the selection of candidates to heart transplantation: CPET was mainly performed in middle‐aged male patients with HF and reduced left ventricular ejection fraction. Today, CPET is used in broader patients' populations, including women, elderly, patients with co‐morbidities, those with preserved ejection fraction, or left ventricular assistance device recipients, i.e. individuals with different responses to incremental exercise and markedly different prognosis. Moreover, the diagnostic and prognostic utility of symptom‐limited CPET parameters derived from submaximal tests is more and more considered, since many patients are unable to achieve maximal aerobic power. Repeated tests are also being used for risk stratification and evaluation of intervention, so that these data are now available. Finally, patients, physicians and healthcare decision makers are increasingly considering how treatments might impact morbidity and quality of life rather than focusing more exclusively on hard endpoints (such as mortality) as was often the case in the past. Innovative prognostic flowcharts, with CPET at their core, that help optimize risk stratification and the selection of management options in HF patients, have been developed.

Từ khóa


Tài liệu tham khảo

10.1161/01.CIR.83.3.778

10.1093/eurheartj/ehn309

10.1093/eurjhf/hfs105

10.1002/ejhf.592

10.1016/j.healun.2015.10.023

10.1016/j.jacc.2007.04.099

10.1002/ejhf.156

10.1016/j.cardfail.2016.01.012

10.1053/euhj.1997.0820

10.1249/00003677-198401000-00004

10.1016/j.resp.2005.10.010

10.1016/S0002-9149(97)00290-7

10.1016/j.ahj.2009.07.012

10.1016/S0002-9149(97)00651-6

10.1016/j.jacc.2005.11.089

10.1016/j.ijcard.2005.11.105

10.1016/j.amjcard.2006.08.046

10.1016/j.amjcard.2007.02.096

10.1016/j.ijcard.2011.12.055

10.1016/j.cjca.2015.09.010

10.1093/eurheartj/ehn539

10.1161/01.CIR.0000048893.62841.F7

10.2459/01.JCM.0000281698.53983.4e

10.1016/j.ahj.2009.07.018

10.1136/heart.83.2.147

10.1067/mhj.2001.115796

10.1136/heart.88.3.239

10.1249/01.MSS.0000084416.71232.EA

10.1016/j.cardfail.2006.12.005

10.1001/jama.288.17.2144

10.1042/CS20080111

10.1016/j.ijcard.2010.05.056

10.1253/circj.CJ-15-0026

10.1016/j.ijcard.2007.10.004

10.1016/j.jacc.2014.01.022

10.1016/j.mayocp.2012.11.020

10.1002/ejhf.534

10.1016/j.amjcard.2007.08.042

10.1016/S0735-1097(00)00985-2

Davos CH, 2003, Lean tissue‐adjusted peak oxygen consumption in chronic heart failure patients, Hellenic J Cardiol, 44, 243

Ingle L, 2012, Influence of body mass on risk prediction during cardiopulmonary exercise testing in patients with chronic heart failure, Exp Clin Cardiol, 17, 179

10.1093/eurheartj/ehn361

10.1016/j.ejim.2015.04.023

10.1177/2047487314551546

Corrà U, 2011, Cardiovascular prevention and rehabilitation for patients with ventricular assist device: from exercise therapy to long‐term therapy. Part I: Exercise therapy, Monaldi Arch Chest Dis, 76, 27

10.1016/j.healun.2014.11.001

10.1161/CIRCULATIONAHA.104.506451

10.1002/ejhf.271

10.1002/ejhf.30

10.1002/ejhf.600

10.1161/CIRCULATIONAHA.109.914788

10.1016/j.ahj.2010.07.014

10.1016/j.ahj.2012.10.029

10.1016/j.jchf.2015.11.003

10.1016/j.ijcard.2015.03.422

10.1371/journal.pone.0087395

10.1164/rccm.200206-583OC

10.1046/j.1475-0961.2003.00514.x

10.1016/j.rmed.2004.11.012

10.1016/j.rmed.2005.03.007

10.1249/MSS.0b013e31817c92c0

10.1159/000186694

10.1016/j.pcad.2011.02.003

10.1093/eurheartj/ehs221

10.1161/CIR.0000000000000406

10.2337/diacare.28.7.1643

10.2337/diacare.21.2.291

10.1016/S0002-9149(01)02199-3

10.1016/S0735-1097(03)00914-8

10.1016/j.jacc.2013.08.693

10.1016/j.healun.2009.01.022

10.1053/j.ajkd.2015.02.335

10.1016/j.jsams.2013.01.005

10.1253/circj.CJ-14-0806

10.1016/S0002-9149(03)00030-4

10.1002/ajh.21698

10.1016/j.cardfail.2007.04.008

10.1016/j.jacc.2006.11.024

10.1093/bja/aeu050

10.23937/2378-2951/1410023

10.1056/NEJMoa0908355

10.1016/j.cardfail.2011.08.003

10.1016/j.ejim.2016.09.011

10.1016/j.ejheart.2005.05.007

10.1016/j.cardfail.2008.08.008

10.1016/j.ijcard.2010.09.002

10.1016/S1470-2045(09)70031-2

10.1016/j.jacc.2014.07.948

10.1200/JCO.2011.39.9014

10.1200/JCO.2010.33.7907

Kelly JO, 2003, Cardiorespiratory fitness and walking ability in subacute stroke patients, Arch Phys Med Rehabil, 84, 1708

10.1161/STR.0000000000000024

10.1111/ijs.12309

10.1159/000346087

10.1161/01.CIR.0000126280.65777.A4

10.1016/j.amjcard.2009.01.025

10.1016/j.hfc.2007.12.002

10.1002/ejhf.198

10.1002/ejhf.184

10.1016/j.amjcard.2008.03.041

10.1016/j.jacc.2005.07.051

10.1093/eurheartj/ehn437

10.1016/j.ahj.2015.12.020

10.1016/j.jchf.2016.03.022

10.1161/CIRCULATIONAHA.112.110460

10.1016/j.ahj.2009.07.014

10.1249/00005768-199509000-00009

10.1016/j.pmr.2008.12.002

10.1016/S0002-8703(03)00100-5

10.1161/01.CIR.101.10.1152

10.1016/j.ijcard.2007.04.075

10.1016/j.jchf.2013.05.008

10.1053/euhj.2000.1737

10.1097/01.hjr.0000189807.22224.54

10.1016/j.ijcard.2006.11.038

10.1016/j.amjcard.2008.04.047

10.1378/chest.09-2624

10.1161/CIRCHEARTFAILURE.109.906446

10.1093/eurjhf/hft095

10.1002/ejhf.516

10.1378/chest.126.3.942

10.1016/j.ijcard.2013.07.192